Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome

Last updated: October 16, 2013
Sponsor: Seoul National University Hospital
Overall Status: Completed

Phase

3

Condition

Collagen Vascular Diseases

Dermatomyositis (Connective Tissue Disease)

Sjogren's Syndrome

Treatment

N/A

Clinical Study ID

NCT01601028
Hydroxychloroquine
  • Ages > 19
  • All Genders

Study Summary

Primary Sjögren syndrome is one of the most prevalent autoimmune diseases that present with dry eye and dry mouth. But there is no proven effective treatment for Sjögren syndrome patient. The relation between toll-like receptor (TLR) and the pathogenesis of Sjögren syndrome has been reported. Hydroxychloroquine is TLR7 and TLR9 antagonist. A few studies have been reported the effectiveness of Hydroxychloroquine for Sjögren syndrome but no randomized controlled study has been done. So the investigators evaluate the effectiveness and safeness of Hydroxychloroquine for primary Sjögren syndrome by randomized controlled study (Hydroxychloroquine 300 mg once daily p.o. group (N = 30) versus placebo group (N = 30).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient who is diagnosed with primary Sjögren syndrome according to American/Europeanconsensus group (AECG) criteria

  • Patient with the ability to give informed, dated and signed consent before thebeginning of any proceedings related to the trial

Exclusion

Exclusion Criteria:

  • Previous treated by Hydroxychloroquine but enough washout time after discontinuance oftreatment, patient can be enrolled. (2 wks)

  • Known cardiac disease, Respiratory disease, Renal disease, Gastrointestinal disease (except GERD)

  • Diabetes mellitus

  • Psoriasis

  • Known drug allergy or hypersensitivity

  • Previous or ongoing treatment by any drugs (include topical drug) which have effect onlacrimal system. But enough washout time after discontinuance of treatment, patientcan be enrolled. (cf. SSRI, Anti-histamine, Pilocarpine, etc.)

  • Angle closer glaucoma

  • Patient who underwent previous intraocular surgery

  • Macular disease

  • Previous or ongoing treatment by drug which could have effect on macula

  • Pregnancy

  • Planning to get pregnant

Study Design

Total Participants: 39
Study Start date:
July 01, 2011
Estimated Completion Date:
August 31, 2013

Connect with a study center

  • Seoul National Unversity Hospital

    Seoul, 110-744
    Korea, Republic of

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.